Aiad, Amany Abd Elaal http://orcid.org/0009-0001-1486-5473
El-Haggar, Sahar Mohamed http://orcid.org/0000-0002-5856-7726
El-Barbary, Amal Mohamed http://orcid.org/0000-0003-2807-4733
El-Afify, Dalia Refat http://orcid.org/0000-0002-1454-4637
Clinical trials referenced in this document:
Documents that mention this clinical trial
Metformin as adjuvant therapy in obese knee osteoarthritis patients
https://doi.org/10.1007/s10787-024-01495-y
Funding for this research was provided by:
Tanta University
Article History
Received: 8 May 2024
Accepted: 15 May 2024
First Online: 13 June 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The study was performed in accordance with the ethical standards of Helsinki declaration in 1964 and its later amendments. The study was approved by the ethical standards of Tanta University Research Ethical Committee (approval code: 34363/1/21). All participants gave their written informed consents. The study was registered as clinical trial on ClinicalTrials.gov with ID: NCT05638893 under the title: Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable and no personal data for any participant are included.